Griebel, Guy <br/><br/>
The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents.  [electronic resource] 

 -  Scientific reports  02 2018 
 - 2416 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-20895-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Amides<br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Anti-Anxiety Agents--chemical synthesis<br/>Anxiety Disorders--drug therapy<br/>Arachidonic Acids--metabolism<br/>Cannabinoid Receptor Agonists--metabolism<br/>Carbamates--chemical synthesis<br/>Chronic Disease<br/>Dioxanes--chemical synthesis<br/>Endocannabinoids--metabolism<br/>Enzyme Inhibitors--chemical synthesis<br/>Ethanolamines--metabolism<br/>Female<br/>Gene Expression<br/>Male<br/>Mice<br/>Oleic Acids--metabolism<br/>Palmitic Acids--metabolism<br/>Polyunsaturated Alkamides--metabolism<br/>Rats, Sprague-Dawley<br/>Receptors, Cannabinoid--genetics<br/>Stress, Psychological--drug therapy